Covered recipient · General Payments record
IURI GOLUBEV
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$5,243.56
- Reported across 57 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,183.57 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $551.02 | 4 |
| Genentech USA, Inc. | $191.08 | 6 |
| Dutch Ophthalmic, USA | $142.92 | 1 |
| Harrow Eye, LLC | $125.00 | 1 |
| Genentech, Inc. | $71.16 | 1 |
| Regeneron Healthcare Solutions, Inc. | $55.65 | 2 |
| Biogen, Inc. | $26.52 | 1 |
| ABBVIE INC. | $20.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.22 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103814080 | CMS |
| Alcon Vision LLC | $148.54 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110698175 | CMS |
| Alcon Vision LLC | $123.73 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110698169 | CMS |
| Alcon Vision LLC | $147.15 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110698173 | CMS |
| Alcon Vision LLC | $131.60 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110698171 | CMS |
| Biogen, Inc. | $26.52 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104869456 | CMS |
| Dutch Ophthalmic, USA | $142.92 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154792394 | CMS |
| Genentech USA, Inc. | $24.87 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133022937 | CMS |
| Genentech USA, Inc. | $23.26 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133022925 | CMS |
| Genentech USA, Inc. | $0.41 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133022929 | CMS |
| Genentech USA, Inc. | $24.13 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133022933 | CMS |
| Genentech USA, Inc. | $26.27 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133022941 | CMS |
| Genentech USA, Inc. | $92.14 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133022916 | CMS |
| Genentech, Inc. | $71.16 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133022921 | CMS |
| Harrow Eye, LLC | $125.00 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145603862 | CMS |
| Regeneron Healthcare Solutions, Inc. | $30.65 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114057608 | CMS |
| Regeneron Healthcare Solutions, Inc. | $25.00 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114057610 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.